CELLECTAR NEW22 DL-00001 (F:NV4) — Stock Price
CELLECTAR NEW22 DL-00001 (F:NV4) is currently trading at €0.25 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.25 and €0.25. This page tracks CELLECTAR NEW22 DL-00001's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CELLECTAR NEW22 DL-00001 (NV4) market capitalisation.
CELLECTAR NEW22 DL-00001 (NV4) Stock Price Chart — Daily History & Trading Volume
The chart below tracks CELLECTAR NEW22 DL-00001's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
Daily price history is not currently available for CELLECTAR NEW22 DL-00001.
CELLECTAR NEW22 DL-00001 Income Statement — Revenue, Profit & Earnings by Year
CELLECTAR NEW22 DL-00001's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year |
|---|
| Total Revenue |
| Cost of Revenue |
| Gross Profit |
| Research & Development |
| SG&A |
| Total Operating Expenses |
| Operating Income |
| EBITDA |
| EBIT |
| Interest Expense |
| Income Before Tax |
| Income Tax Expense |
| Net Income |
CELLECTAR NEW22 DL-00001 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes CELLECTAR NEW22 DL-00001's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year |
|---|
| Total Assets |
| Total Current Assets |
| Cash & Equivalents |
| Short-term Investments |
| Net Receivables |
| Inventory |
| Property, Plant & Equipment |
| Goodwill |
| Total Liabilities |
| Total Current Liabilities |
| Long-term Debt |
| Net Debt |
| Total Stockholder Equity |
| Retained Earnings |
CELLECTAR NEW22 DL-00001 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how CELLECTAR NEW22 DL-00001 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year |
|---|
| Operating Cash Flow |
| Capital Expenditures |
| Free Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Dividends Paid |
| Stock-Based Compensation |
| Depreciation |
| Change in Cash |
CELLECTAR NEW22 DL-00001 Earnings History — EPS Actual vs. Analyst Estimates
Track CELLECTAR NEW22 DL-00001's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Mar 11, 2026 | — | — | — |
| Nov 14, 2025 | — | -2.53 | — |
| Aug 11, 2025 | — | — | — |
| May 12, 2025 | — | — | — |
| Mar 25, 2025 | — | — | — |